News
03-24-2022, 01:50 AM
A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, two commonly used breast cancer chemotherapies.
More... (https://www.news-medical.net/news/20220323/Study-uncovers-a-gene-that-strongly-associates-with-breast-cancer-patients-treatment-outcomes.aspx)
More... (https://www.news-medical.net/news/20220323/Study-uncovers-a-gene-that-strongly-associates-with-breast-cancer-patients-treatment-outcomes.aspx)